| Metric | FY 2025↕ | FY 2024↕ | FY 2023↕ | FY 2022↕ | FY 2021↕ | FY 2020↕ | FY 2019↕ | FY 2018↕ |
|---|---|---|---|---|---|---|---|---|
| Revenue | $0.1B | $0.1B | $0.1B | $0.1B | $0.1B | $0.0B | $0.0B | $0.0B |
| Cost of Revenue | — | — | — | — | — | — | — | — |
| Gross Profit | — | — | — | — | — | — | — | — |
| R&D Expense | — | — | — | — | — | — | — | — |
| SG&A Expense | — | — | — | — | — | — | — | — |
| Operating Income | — | — | — | — | — | — | — | — |
| Net Income | $0.3B | $0.1B | $0.1B | $0.2B | $0.2B | $0.0B | $0.0B | $0.0B |
| EPS (Basic) | $2.23 | $1.05 | $1.72 | $2.35 | $2.20 | $0.53 | $0.40 | $0.55 |
| EPS (Diluted) | $2.23 | $1.05 | $1.71 | $2.35 | $2.19 | $0.53 | $0.40 | $0.55 |
| Metric | FY 2025↕ | FY 2024↕ | FY 2023↕ | FY 2022↕ | FY 2021↕ | FY 2020↕ | FY 2019↕ | FY 2018↕ |
|---|---|---|---|---|---|---|---|---|
| Total Assets | $25.0B | $24.1B | $14.2B | $13.8B | $13.8B | $12.9B | $9.8B | $9.7B |
| Current Assets | — | — | — | — | — | — | — | — |
| Cash & Equivalents | $0.2B | $0.2B | $0.2B | $0.2B | $0.7B | — | — | $0.1B |
| Total Liabilities | $22.1B | $21.5B | $12.5B | $12.2B | $12.1B | $11.3B | $8.4B | $8.4B |
| Current Liabilities | — | — | — | — | — | — | — | — |
| Stockholders' Equity | $2.8B | $2.6B | $1.7B | $1.6B | $1.7B | $1.6B | $1.4B | $1.4B |
| Metric | FY 2025↕ | FY 2024↕ | FY 2023↕ | FY 2022↕ | FY 2021↕ | FY 2020↕ | FY 2019↕ | FY 2018↕ |
|---|---|---|---|---|---|---|---|---|
| Operating Cash Flow | $0.4B | $0.4B | $0.2B | $0.2B | $0.2B | $0.1B | $0.1B | $0.2B |
| Investing Cash Flow | $-1.1B | $0.5B | $-0.5B | $-0.6B | $-0.7B | $-0.5B | $0.0B | $0.0B |
| Capital Expenditures | $0.0B | $0.0B | $0.0B | $0.0B | $0.0B | $0.0B | $0.0B | $0.0B |
| Financing Cash Flow | $0.6B | $-0.9B | $0.3B | $-0.1B | $0.7B | $0.7B | $-0.1B | $-0.3B |